Table 1.
Overall (N = 481)1 | |
---|---|
Age | |
Pre-term neonate | 44 (9.1%) |
Full-term neonate | 203 (42.2%) |
Infant | 114 (23.7%) |
Child | 77 (16.0%) |
Adolescent | 43 (8.9%) |
Male | 283 (58.8%) |
Race | |
White | 232 (48.2%) |
Black or African American | 87 (18.1%) |
Other | 26 (5.4%) |
Unknown/Not Reported | 136 (28.3%) |
Hispanic or Latino | 82 (17.0%) |
Infection prior to or during the first 24 hours of ECMO | |
None | 235 (48.9%) |
Suspected | 148 (30.8%) |
Bacterial | 49 (10.2%) |
Viral | 32 (6.7%) |
Fungal | 6 (1.2%) |
Multiple | 11 (2.3%) |
Location of ECMO care | |
PICU | 100 (20.8%) |
NICU | 151 (31.4%) |
CICU | 230 (47.8%) |
Mode of ECMO | |
VA | 400 (83.2%) |
VV | 81 (16.8%) |
Baseline Vasoactive Inotropic Score2 | |
None | 140 (29.1%) |
Low | 155 (32.2%) |
High | 186 (38.7%) |
Primary ECMO indication | |
Respiratory | 229 (47.6%) |
Cardiac | 184 (38.3%) |
ECPR | 68 (14.1%) |
ECMO: extracorporeal membrane oxygenation; PICU: pediatric intensive care unit; NICU: neonatal intensive care unit; CICU: cardiac intensive care unit; VA: venoarterial; VV: venovenous; ECPR: extracorporeal cardiopulmonary resuscitation.
Data are expressed as counts and column percentages.
None is Vasoactive Inotropic Score (VIS) =0, low is VIS >0 and <20 and high is VIS ≥20.